Literature DB >> 800403

Isolation of human eosinophils and their lymphocyte-like rosetting properties.

R Sher, A Glover.   

Abstract

A method for the isolation of large numbers of almost pure human eosinophils from peripheral blood using hypague-ficoll density gradients, gelatin sedimentation and carbonyl iron is described. Eosinophils were obtained from patients with parasitic infections, allergic reactions, undiagnosed eosinophilias and normal volunteers. Erythrocyte (E) and erythrocyte-antibody-complement (EAC) rosettes were formed by a number of eosinophils.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 800403      PMCID: PMC1445251     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  6 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  An extension of the 51Cr-release assay for the estimation of mouse cytotoxins.

Authors:  W Boyle
Journal:  Transplantation       Date:  1968-09       Impact factor: 4.939

3.  Eosinophil cell separation from human peripheral blood.

Authors:  R P Day
Journal:  Immunology       Date:  1970-06       Impact factor: 7.397

4.  T and CR+ lymphocyte profile in leprosy and the effect of treatment.

Authors:  R Sher; G Holm; S H Kok; H J Koornhof; A Glover
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

5.  Role of the eosinophil in the allergic reactions. I. EDI-an eosinophil-derived inhibitor of histamine release.

Authors:  T Hubscher
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

6.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

  6 in total
  10 in total

1.  Purification of normal human eosinophils using the different binding capacities of blood leucocytes for complexed rabbit IgG.

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

Review 2.  Eosinophils. Assays and interpretation.

Authors:  D E Maddox
Journal:  Clin Rev Allergy       Date:  1988

3.  Eosinophil degranulation. Monitoring by interference contrast microscopy.

Authors:  R Sher; A A Wadee
Journal:  Inflammation       Date:  1981-03       Impact factor: 4.092

4.  An improved method for the isolation of eosinophilic leukocytes from normal human blood.

Authors:  P Portmann; P Köppel; A Jörg
Journal:  Experientia       Date:  1980-01-15

5.  Antibody-dependent cellular cytotoxicity of Trypanosoma cruzi: characterization of the effector cell from normal human blood.

Authors:  E D Madeira; A F de Andrade; M M Bunn-Moreno; M Barcinski
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

6.  Human eosinophils and parasitic diseases: light and electron microscopy evidence of interaction with sheep erythrocyte.

Authors:  C de Simone; G Donelli; D Meli; F Rosati; F Sorice
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

7.  The effects of a soluble factor released by sensitized mononuclear cells incubated with S. haematobium ova on eosinophil migration.

Authors:  A A Wadee; R Sher
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

8.  The enhancement of eosinophil function by lymphocyte supernatants.

Authors:  R Sher; A Wadee; M Joffe
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

9.  The role of gene products of the I-J subregion in mixed lymphocyte reactions.

Authors:  K Okuda; C S David; D C Shreffler
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

10.  Complement-mediated killing of schistosomula of Schistosoma mansoni by rat eosinophils in vitro.

Authors:  F J Ramalho-Pinto; D J McLaren; S R Smithers
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.